Seawolf Capital Lowered Phh (PHH) Position, Bell State Bank & Trust Raised Its Pfizer (PFE) Holding

June 8, 2017 - By marketbeat

Seawolf Capital Llc decreased Phh Corp (PHH) stake by 7.71% reported in 2016Q4 SEC filing. Seawolf Capital Llc sold 33,960 shares as Phh Corp (PHH)’s stock rose 10.02%. The Seawolf Capital Llc holds 406,550 shares with $6.16M value, down from 440,510 last quarter. Phh Corp now has $747.38 million valuation. The stock rose 0.80% or $0.11 reaching $13.9. About 111,713 shares traded. PHH Corporation (NYSE:PHH) has risen 6.41% since June 8, 2016 and is uptrending. It has underperformed by 10.29% the S&P500.

Bell State Bank & Trust increased Pfizer Inc (PFE) stake by 1183.62% reported in 2016Q4 SEC filing. Bell State Bank & Trust acquired 106,396 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Bell State Bank & Trust holds 115,385 shares with $3.75M value, up from 8,989 last quarter. Pfizer Inc now has $189.88 billion valuation. The stock declined 0.11% or $0.03 reaching $31.95 on the news. About 9.51M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since June 8, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Since February 27, 2017, it had 0 buys, and 5 insider sales for $5.16 million activity. $1.23 million worth of Pfizer Inc. (NYSE:PFE) was sold by HILL CHARLES H. $693,200 worth of Pfizer Inc. (NYSE:PFE) shares were sold by LANKLER DOUGLAS M. Shares for $153,855 were sold by JOHNSON RADY A on Friday, March 10. On Monday, February 27 Dolsten Mikael sold $2.02M worth of Pfizer Inc. (NYSE:PFE) or 58,846 shares.

Among 20 analysts covering Pfizer (NYSE:PFE), 7 have Buy rating, 1 Sell and 12 Hold. Therefore 35% are positive. Pfizer had 44 analyst reports since July 29, 2015 according to SRatingsIntel. The company was initiated on Thursday, May 12 by Berenberg. The company was maintained on Monday, June 20 by Jefferies. The stock of Pfizer Inc. (NYSE:PFE) earned “Overweight” rating by JP Morgan on Thursday, April 7. As per Tuesday, May 16, the company rating was downgraded by Citigroup. The stock of Pfizer Inc. (NYSE:PFE) earned “Overweight” rating by Barclays Capital on Tuesday, November 29. The stock of Pfizer Inc. (NYSE:PFE) has “Overweight” rating given on Friday, August 28 by Piper Jaffray. The company was maintained on Wednesday, July 29 by Argus Research. Goldman Sachs maintained the stock with “Neutral” rating in Monday, April 18 report. BMO Capital Markets downgraded the stock to “Market Perform” rating in Wednesday, November 2 report. The stock of Pfizer Inc. (NYSE:PFE) earned “Equal-Weight” rating by Barclays Capital on Tuesday, December 1.

Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.05, from 1.18 in 2016Q3. It turned negative, as 60 investors sold PFE shares while 672 reduced holdings. 115 funds opened positions while 711 raised stakes. 4.12 billion shares or 1.11% more from 4.08 billion shares in 2016Q3 were reported. Train Babcock Advsrs Ltd Co has 15,160 shares. Old Natl Fincl Bank In has 1.14% invested in Pfizer Inc. (NYSE:PFE). South State Corporation reported 1.01% of its portfolio in Pfizer Inc. (NYSE:PFE). 347,868 were reported by Commonwealth Of Pennsylvania Pub School Empls Retrmt Systems. Geneva Llc reported 214,892 shares. Ledyard Savings Bank holds 2.1% in Pfizer Inc. (NYSE:PFE) or 363,735 shares. Hanson Mcclain Inc stated it has 0.05% in Pfizer Inc. (NYSE:PFE). Cap Mgmt Associate New York stated it has 1.02% in Pfizer Inc. (NYSE:PFE). Fayerweather Charles reported 9,675 shares. Honeywell Intl holds 1.47% or 1.35 million shares. Foundation Mgmt has invested 8.56% of its portfolio in Pfizer Inc. (NYSE:PFE). Grandfield Dodd Ltd Liability holds 0.35% of its portfolio in Pfizer Inc. (NYSE:PFE) for 82,980 shares. Hugh Johnson Advisors Ltd holds 29,938 shares. Balasa Dinverno Foltz reported 0.21% stake. Pettee Investors holds 4.58% of its portfolio in Pfizer Inc. (NYSE:PFE) for 148,235 shares.

Among 10 analysts covering PHH Corporation (NYSE:PHH), 5 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. PHH Corporation had 13 analyst reports since August 7, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Outperform” rating in Tuesday, August 11 report. On Friday, March 3 the stock rating was upgraded by Wedbush to “Outperform”. The rating was upgraded by Wood on Monday, August 10 to “Market Perform”. The company was upgraded on Wednesday, September 30 by Compass Point. The rating was maintained by Morgan Stanley on Tuesday, August 11 with “Equal Weight”. The rating was downgraded by Sterne Agee CRT on Tuesday, April 12 to “Neutral”. The stock of PHH Corporation (NYSE:PHH) earned “Outperform” rating by Bruyette & Woods” on Monday, August 10. The stock of PHH Corporation (NYSE:PHH) earned “Strong Sell” rating by ValuEngine on Friday, May 26. The stock of PHH Corporation (NYSE:PHH) has “Market Perform” rating given on Friday, August 7 by FBR Capital. The stock of PHH Corporation (NYSE:PHH) earned “Outperform” rating by KBW on Monday, August 10.

Since May 10, 2017, it had 0 insider buys, and 1 insider sale for $1.42 million activity. Another trade for 107,299 shares valued at $1.42 million was sold by Silver Point Capital L.P..